# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Richard Roundtree (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML015-SYN
- Date: 2026-09-29
- Fictional facility: St. Posthumous Health Center
- Fictional author: Leon Carrington, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for new painless lump under the left nipple in a man of 51. **S**

## Objective

PHQ-2: 1. All results are synthetic.

BP 128/80 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 99% on room air; weight 86 kg; BMI 24.3 kg/m². All vital signs are synthetic.

## Assessment

Active problems: New firm, painless lump of about 1.5 cm just off the left nipple, with a palpable left axillary node; suspected breast cancer, imaging and core biopsy booked. Strengths and supports remain part of the care plan. **S**

## Medication changes

- No medication changes. **S**

## Plan

- Urgent surgical oncology (breast) consultation for a suspected breast cancer with an abnormal left axillary node, core biopsy pending, to plan the operation and the axilla. Guideline: Hassett MJ, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol 2020;38(16):1849-1863 (2020); NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025) **S**
- Same-week diagnostic mammography and ultrasound of both breasts and both axillae, and ultrasound-guided core biopsy of the mass and the abnormal node with ER, PR, and HER2 testing. Guideline: Hassett MJ, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol 2020;38(16):1849-1863 (2020); NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025) **S**
- Distress screening at each visit, plain information that men get breast cancer, confidential handling of his diagnosis at work, and the offer of a peer-support group for men with breast cancer. Guideline: Runowicz CD, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 2016;66(1):43-73 (2016); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026) **S**
